Compositions for diabetes treatment and prophylaxis

Details Compositions for diabetes treatment and prophylaxis Compositions for diabetes treatment and prophylaxis

2005-09-27

2005-09-27

Page, Thurman K. (Department: 1618)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

C424S400000, C424S489000, C424S499000, C424S774000

Reexamination Certificate

active

06949261

ABSTRACT:
An isolate from the leaves ofGymnema sylvestre, having a specified molecular weight, is useful for the treatment of diabetes. The isolate has a molecular weight at least about 3000 Daltons as determined by molecular weight cut-off filtration. Glucose metabolism in a human patient is regulated by dosage forms that contain the aforesaid isolate from the leaves ofGymnema sylvestre, optionally in combination with a non-metabolizable polysaccharide such as the exudate ofSterculia urens.

REFERENCES:
patent: 4761286 (1988-08-01), Hiji
patent: 4824672 (1989-04-01), Day et al.
patent: 4883788 (1989-11-01), Day et al.
patent: 4988682 (1991-01-01), Kozikowski
patent: 5063210 (1991-11-01), Lange, III et al.
patent: 5137921 (1992-08-01), Kensho et al.
patent: 5176937 (1993-01-01), Kurihara et al.
patent: 5178899 (1993-01-01), Kurihara et al.
patent: 5242693 (1993-09-01), Kurihara et al.
patent: 5244887 (1993-09-01), Straub
patent: 5484777 (1996-01-01), Lange, III et al.
patent: 5641511 (1997-06-01), Kuhrts
patent: 5730988 (1998-03-01), Womack
patent: 5773427 (1998-06-01), Day
patent: 5843909 (1998-12-01), Atsuchi et al.
patent: 5900240 (1999-05-01), Tomer et al.
patent: 6133237 (2000-10-01), Noll et al.
patent: 6187753 (2001-02-01), Noll et al.
patent: 6376481 (2002-04-01), Bruce et al.
patent: 6455068 (2002-09-01), Licari
patent: WO 95/10292 (1995-04-01), None
Fletcher, J.I. et al. “High-resolution solution structure of gurmarin, a sweet-taste-suppressing plant polypeptide”. Eur. J. Biochem. 264 (1999): 525-533.
Kazumasa Shimizu, et al. “Suppression of Glucose Absorption by Some Fractions Extracted fromGymnema sylvestreLeaves,” J. Vet. Med. Sci., vol. 59 (4); pp. 245-251 (1997).
Harry G. Preuss, M.D., et al., “Comparative Effects of Chromium, Vanadium and Gymnema Sylvestre on Sugar-Induced Blood Pressure Elevations in SHR,” Journal of American College of Nutrition, vol. 17(2); pp. 116-123 (1998).
Yumiko Nakamura, et al., “Fecal Steroid Excretion is Increased in Rats by Oral Administration of Gymnemic Acids Contained inGymnema sylvestreLeaves,” J. Nutr., vol. 129, pp. 1214-1222 (1999).
K. Baskaran, et al. “Antidiabetic Effect of a Leaf Extract FromGymnema sylvestrein Non-Insulin-Dependent Diabetes Mellitus Patients,” Journal of Ethnopharmacology, vol. 30, pp. 295-305 (pp. 1990).
E.R.B. Shanmugasundaram, et al., “Use ofGymnema sylvestreLeaf Extract in the Control of Blood Glucose in Insulin-Dependent Diabetes Mellitus,” Journal of Ethnopharmacology, vol. 30, pp. 281-294 (1990).
E.R.B. Shanmugasundaram, et al., “Possible Regeneration of the Islets of Langerhans in Streptozotocin-Diabetic Rats GivenGymnema sylvesreLeaf Extracts,” Journal of Ethnopharmacology, vol. 30, pp. 265-279 (1990).
Y. Okabayashi, et al., “Effect ofGymnema sylvestre, R.Br. on Glucose Homeostatis in Rats,” Diabetes Research and Clinical Practice, vol. 9 (2), pp. 143-148 (1990).
D.J. Joffe, “Effect of Extended ReleaseGymnema SylvestreLeaf Extract . . . ,” Diabetes in Control Newsletter, Issue 76(1): pp. 1-4 (Oct. 30, 2001).
K.R. Shanmugasundaram, et al., Enzyme Changes and Glucose Utilization in Diabetic Rabbits: The Effect ofGymnema sylvestre, R.Br., Journal of Ethnopharmacology, vol. 7, pp. 205-234 (1983).
S.K. Baveja, et al., “Examination of Natural Gums and Mucilages as Sustaining Materials in Tablet Dosage Forms—Part II, ” Indian Journal of Pharmaceutical Sciences, vol. 51 (4), pp. 115-118 (Mar., 1988).
Toshiaki Imoto et al., “A Novel Peptide Isolated From the Leaves ofGymnema sylvestre. . . ”, Comp. Biochem. Physiol. 100A(2): 309-314 (1991).

Affiliated with

Also associated with

Rating

Compositions for diabetes treatment and prophylaxis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for diabetes treatment and prophylaxis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for diabetes treatment and prophylaxis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3371564